UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 327

Sortiert nach

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients

Annals of oncology, 2010-04, Vol.21 (4), p.815-819

2010

Link zum Volltext

Verfügbarkeit prüfen

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes

Annals of oncology, 2024-04, Vol.35 (4), p.392-401

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

Annals of oncology, 2011-11, Vol.22 (11), p.2476-2481

2011

Link zum Volltext

Verfügbarkeit prüfen

French ccAFU guidelines - update 2020-2022: prostate cancer

Progrès en urologie (Paris), 2020-11, Vol.30 (12S), p.S136-S251

2020

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Use of Radiosurgery for Brain Metastases and TDM1 in HER2-Positive Metastatic Breast

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E75-E76

2016

Link zum Volltext

Verfügbarkeit prüfen

Patient reported outcomes: Web-monitoring versus nurse assessment to improve anticancer therapies

Annals of oncology, 2018-10, Vol.29, p.viii621-viii622

2018

Link zum Volltext

Verfügbarkeit prüfen

Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer

European urology, 2009-04, Vol.55 (4), p.992-992

Beuzeboc, P

2009

Link zum Volltext

Verfügbarkeit prüfen

Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience

Annals of oncology, 2011-04, Vol.22 (4), p.848-856

2011

Link zum Volltext

Verfügbarkeit prüfen

Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study

Breast cancer research and treatment, 2014-11, Vol.148 (2), p.345-353

2014

Link zum Volltext

Verfügbarkeit prüfen

CCAFU french national guidelines 2016-2018 on prostate cancer

Progrès en urologie (Paris), 2016-11, Vol.27 Suppl 1, p.S95-S143

2016

Link zum Volltext

Verfügbarkeit prüfen

French ccAFU guidelines - Update 2018-2020: Prostate cancer

Progrès en urologie (Paris), 2018-11, Vol.28 Suppl 1, p.R81-R132

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study

Annals of oncology, 2018-10, Vol.29, p.viii109-viii109

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting HER2 in other tumor types

Annals of oncology, 2001, Vol.12, p.81-87

2001

Link zum Volltext

Verfügbarkeit prüfen

2191 Decreased overall survival in colorectal cancer patients with renal insufficiency

European journal of cancer (1990), 2015-09, Vol.51, p.S397-S397

2015

Link zum Volltext

Verfügbarkeit prüfen

CCAFU Recommendations 2013: Prostate cancer

Progrès en urologie (Paris), 2013-11, Vol.23 Suppl 2, p.S69-101

2013

Link zum Volltext

Verfügbarkeit prüfen

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients

Annals of oncology, 2007-11, Vol.18 (11), p.1828-1833

2007

Link zum Volltext

Verfügbarkeit prüfen

French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020

Progrès en urologie (Paris), 2020-06, Vol.30 (8-9), p.430-438

2020

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “French ccAFU guidelines–update 2020–2022: Prostate cancer” [Prog. Urol 30 (12 S) (2020), pp S136-S251]

Progrès en urologie (Paris), 2021-05, Vol.31 (6), p.381-382

2021

Link zum Volltext

Verfügbarkeit prüfen

The androgen receptor for the radiation oncologist

Cancer radiothérapie, 2015-05, Vol.19 (3), p.220-227

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study

Breast (Edinburgh), 2015-12, Vol.24 (6), p.718-722

2015

Link zum Volltext

Verfügbarkeit prüfen

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

Breast (Edinburgh), 2015-08, Vol.24 (4), p.376-383

2015

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer

Cancer radiothérapie, 2016-06, Vol.20 (4), p.312-313

2016

Link zum Volltext

Verfügbarkeit prüfen

Cardiotoxicity of the Association Trastuzumab–Locoregional Breast Radiation Therapy: A Prospective Monocentric Study

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S212-S212

2013

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age

Breast (Edinburgh), 2004-10, Vol.13 (5), p.369-375

2004

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e219-e220

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(311)
Mit Volltextzugriff
(265)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(147)
Life Sciences & Biomedicine
(102)
Science & Technology
(102)
Female
(83)
Middle Aged
(75)
Male
(68)
Aged
(64)
Adult
(59)
Oncology
(59)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(42)
Breast Neoplasms - Drug Therapy
(38)
Sciences Biologiques Et Medicales
(36)
Sciences Medicales
(36)
Treatment Outcome
(31)
Urology & Nephrology
(28)
Chemotherapy
(27)
Breast Neoplasms - Pathology
(26)
Prostate Cancer
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

French ccAFU guidelines - update 2020-2022: prostate cancer

Concurrent Use of Radiosurgery for Brain Metastases and TDM1 in HER2-Positive Metastatic Breast

Patient reported outcomes: Web-monitoring versus nurse assessment to improve anticancer therapies

Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer

Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience

Concurrent administration of trastuzumab with locoregional breast radiotherapy: long-term results of a prospective study

CCAFU french national guidelines 2016-2018 on prostate cancer

French ccAFU guidelines - Update 2018-2020: Prostate cancer

Breast cancer (BC) treatment (tx) with everolimus (EVE) and exemestane (EXE) in hormone receptor positive (HR+)/ HER2-negative (HER2−) postmenopausal women: Final analysis of the French observational TANGO study

Targeting HER2 in other tumor types

2191 Decreased overall survival in colorectal cancer patients with renal insufficiency

CCAFU Recommendations 2013: Prostate cancer

Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients

French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020

Corrigendum to “French ccAFU guidelines–update 2020–2022: Prostate cancer” [Prog. Urol 30 (12 S) (2020), pp S136-S251]

The androgen receptor for the radiation oncologist

Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study

Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA

Preliminary results of the concurrent use of radiotherapy for bone metastases and trastuzumab emtansine in patients with HER2-positive metastatic breast cancer

Cardiotoxicity of the Association Trastuzumab–Locoregional Breast Radiation Therapy: A Prospective Monocentric Study

Characteristics and outcome of 1755 operable breast cancers in women over 70 years of age

Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience

Suchergebnisse filtern